Merck Other Operating Income or Expenses 2010-2024 | MKKGY

Merck annual/quarterly other operating income or expenses history and growth rate from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
  • Merck other operating income or expenses for the quarter ending June 30, 2024 were $-0.335B, a 181.79% increase year-over-year.
  • Merck other operating income or expenses for the twelve months ending June 30, 2024 were $-0.535B, a 35.12% decline year-over-year.
  • Merck annual other operating income or expenses for 2023 were $-0.472B, a 35.09% decline from 2022.
  • Merck annual other operating income or expenses for 2022 were $-0.727B, a 199.74% increase from 2021.
  • Merck annual other operating income or expenses for 2021 were $-0.243B, a 584.92% increase from 2020.
Merck Annual Other Operating Income or Expenses
(Millions of US $)
2023 $-472
2022 $-727
2021 $-243
2020 $-35
2019 $-31
2018 $-149
2017 $328
2016 $17
2015 $-496
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Merck Quarterly Other Operating Income or Expenses
(Millions of US $)
2024-06-30 $-335
2024-03-31 $-85
2023-12-31 $-83
2023-09-30 $-33
2023-06-30 $-119
2023-03-31 $-237
2022-12-31 $-237
2022-09-30 $-233
2022-06-30 $-170
2022-03-31 $-88
2021-12-31 $-94
2021-09-30 $-35
2021-06-30 $-98
2021-03-31 $-16
2020-12-31 $-122
2020-09-30 $348
2020-06-30 $-182
2020-03-31 $-81
2019-12-31 $18
2019-09-30 $-46
2019-06-30 $91
2019-03-31 $-94
2018-12-31 $62
2018-09-30 $-64
2018-06-30 $-142
2018-03-31 $-5
2017-12-31 $-280
2017-09-30 $437
2017-06-30 $69
2017-03-31 $101
2016-12-31 $-97
2016-09-30 $-57
2016-06-30 $-134
2016-03-31 $304
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $21.306B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
New York Community Bancorp (FLG) United States $4.269B 0.00
Acasti Pharma (GRCE) Canada $0.033B 0.00